Effects of Basal Insulin Analogue Detemir on Body Composition, Epicardial Fat and Energy Metabolism.

Trial Profile

Effects of Basal Insulin Analogue Detemir on Body Composition, Epicardial Fat and Energy Metabolism.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Jan 2015

At a glance

  • Drugs Insulin detemir (Primary) ; Insulin glargine
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 06 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov..
    • 03 Sep 2013 Planned End Date changed from 1 Dec 2011 to 1 Jul 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top